Skip to content
TriangleGet started
← Transitional Cell Cancer of the Renal Pelvis and Ureter

FOR PATIENTS · SOURCE READING

Surgery

Source: Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 16, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview for Transitional Cell Cancer of the Renal Pelvis and Ureter / The following type of treatment is used:

One of the following surgical procedures may be used to treat transitional cell cancer of the renal pelvis and ureter:

Nephroureterectomy is surgery to remove the entire kidney, the ureter, and the bladder cuff (tissue that connects the ureter to the bladder). Most people with transitional cell cancer of the renal pelvis and ureter undergo nephroureterectomy.

Source links and citations

Segmental resection of the ureter is a surgical procedure to remove the part of the ureter that contains cancer and some of the healthy tissue around it. The ends of the ureter are then reattached. This treatment is used when the cancer is superficial and in the lower third of the ureter only, near the bladder.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice